Skip to the page

Data / Form D filings / Transradial Technologies, Inc.

Transradial Technologies, Inc.: Form D filing

Transradial Technologies, Inc., a health care company in Syracuse, NY, filed a Form D with the SEC in 2024. The latest, on November 20, 2024, reports $350,000 sold of a $3 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2930 E. GENESSEE ST., Syracuse, NY, 13224
Phone
(215) 688-6196
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
No Revenues
Exemptions claimed
Rule 506(b), 04.3
SEC identifier (CIK)
2045475

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 20, 2024New notice$3,000,000$350,000$2,650,0003Nov 13, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephen Michael GreenExecutive Officer, Director
Randolph Wayne HubbellExecutive Officer, Director
Ronald Paul CaputoExecutive Officer, Director

Other health care companies in New York that filed recently

Every Form D from the week of Nov 18, 2024 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Transradial Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.